CR1 and CR1-like: The primate immune adherence receptors

Immunological Reviews

Volumn 180, Issue , 2001, Pages 100-111

  Birmingham, Daniel J ^a   Hebert, Lee A ^a  

^a Davis Heart and Lung Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; GENE PRODUCT;

ANTIGEN ANTIBODY COMPLEX; COMPLEMENT FIXATION; ERYTHROCYTE; IMMUNE ADHERENCE; LIVER; MONOCYTE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIMATE; PRIORITY JOURNAL; REVIEW; SPLEEN; STRUCTURE ACTIVITY RELATION;

ALLELES; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BACTERIA; CELL ADHESION; CHROMOSOMES, HUMAN, PAIR 1; COMPLEMENT ACTIVATION; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FORECASTING; HUMANS; LIGANDS; LIVER; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACACA FASCICULARIS; OPSONIN PROTEINS; PAN TROGLODYTES; PAPIO; PRIMATES; PROTEIN ISOFORMS; RECEPTORS, COMPLEMENT 3B; REPETITIVE SEQUENCES, AMINO ACID; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUSES;

EID: 0035014367     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1800109.x     Document Type: Review

References (119)

1. 1. Duke HL, Wallace JM. "Red-cell adhesion" in trypanosomiasis of man and animals. Parasitology 1930;22:414-456.
2. 2. Wallace JM, Wormall A. Red-cell adhesion in trypanosomiasis of man and other animals, II. Some experiments in the mechanism of the reaction. Parasitology 1931;23:346-359.
3. 3. Brown HC, Broom JC. Studies in trypanosomiasis, II. Observations on the red cell adhesion test. Trans R Soc Trop Med Hyg 1938;32:209-222.
4. 4. Nelson RA. The immune-adherence phenomonon: an immunologically specific reaction between microorgansims and erythrocytes leading to enhanced phagocytosis. Science 1953;118:733-737.
5. 5. Taverne J. Immune-adherence of bacteriophage T2. Br J Exp Pathol 1957;38:377-384.
6. 6. Nelson RA. The immune-adherence phenomonon: a hypothetical role of erythrocytes in defense against bacteria and viruses. Proc R Soc Med 1956;49:55-58.
7. 7. Brody JI. Reactivity of red cell eluates and serums in patients with acquired hemolytic anemia and chronic lymphocytic leukemia. J Clin Invest 1962;41:471-479.
8. 8. Turk JL. Immune-adherence with soluble antigens. Immunology 1958;1:305-314.
9. 9. Nishioka K, Linscott WD. Components of guinea pig complement. I. Separation of a serum fraction essential for immune hemolysis and immune adherence. J Exp Med 1963;118:767-793.
10. 10-globulin (C′3) in immune hemolysis. J Exp Med 1966;123:33-54.
11. 11. Cooper N. Immune adherence by the fourth component of complement. Science 1969;165:396-398.
12. 12. Tack BF, Harrison RA, Janatova J, Thomas ML, Prahl JW. Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci USA 1980;77:5764-5768.
13. 13. Schreiber RD, Pangburn MK, Muller-Eberhard HJ. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors. Biosci Rep 1981;1:873-880.
14. 14. Isenman DE, Kells DI, Cooper NR, Muller-Eberhard HJ, Pangburn MK. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry 1981;20:4458-4467.
15. 15. Harrison RA, Thomas ML, Tack BF. Sequence determination of the thiolester site of the fourth component of human complement. Froc Natl Acad Sci USA 1981;78:7388-7392.
16. 16. Bianco C, Patrick R, Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med 1970;132:702-720.
17. 17. Lay WH, Nussenzweig V. Receptors for complement on leukocytes. J Exp Med 1968;128:991-1009.
18. 18. Huber H, Fudenberg HH. The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol 1970;3:160-175.
19. 19. Wong L, Wilson JD. The identification of Fc and C3 receptors on human neutrophils. J Immunol Methods 1975;7:69-76.
20. 20. Gelfand MC, Frank MM, Green I. A receptor for the third component of complement in the human renal glomerulus. J Exp Med 1975;142:1029-1034.
21. 21. Ross GD. Surface markers of B and T cells. Recent technical developments reveal a heterogeneity of lymphocyte subpopulations. Arch Pathol Lab Med 1977;101:337-341.
22. 22. Ross GD, Polley MJ, Rabellino EM, Grey HM. Two different complement receptors on human lymphocyte. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med 1973;138:798-811.
23. 23. Ross GD, Rabellino EM. Identification of a neutrophil and monocyte complement receptor (CR3) that is distinct from lymphocyte CR1 and CR2 and specific for a site contained within C3bi. Fed Proc 1979;38:1467.
24. 24. Ross GD, Medof ME. Membrane complement receptors specific for bound fragments of C3. Adv Immunol 1985;37:217-267.
25. 25. Fearon DT. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci USA 1979;76:5867-5871.
26. 26. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med 1980;152:20-30.
27. 27. Hourcade DE, Holers VM, Atkinson JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989;45:381-416.
28. 28. Klickstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, Fearon DT. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med 1987;165:1095-1112.
29. 29. Dykman TR, Cole JL, Iida K, Atkinson JP. Polymorphism of human erythrocyte C3b/ C4b receptor. Proc Natl Acad Sci USA 1983;80:1698-1702.
30. 30. Dykman TR, Hatch JA, Atkinson JP. Polymorphism of the human C3b/C4b receptor; Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J Exp Med 1984;159:691-703.
31. 31. Dykman TR, Hatch JA, Aqua MS, Atkinson JP. Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J Immunol 1985;134:1787-1789.
32. 32. Wong WW, Wilson JG, Fearon DT. Genetic regulation of a structural polymorphism of human C3b receptor. J Clin Invest 1983;72:685-693.
33. 33. Wong WW, et al. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype. J Exp Med 1986;164:1531-1546.
34. 34. Moulds JM, et al. Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998;15:291-294.
35. 35. Van Dyne S, Holers VM, Lublin DM, Atkinson JP. The polymorphism of the C3b/ C4b receptor in the normal population and in patients with systemic lupus erythematosus. Clin Exp Immunol 1987;68:570-579.
36. 36. Hourcade D, Miesner DR, Atkinson JP, Holers VM. Identification of an alternative polyadenylation site in the human C3b/ C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J Exp Med 1988;168:1255-1270.
37. 37. Wong WW, et al. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J Exp Med 1989;169:847-863.
38. 38. Wong WW, Farrell SA. Proposed structure of the F′ allotype of human CR1. Loss of a C3b binding site may be associated with altered function. J Immunol 1991;146:656-662.
39. 39. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 On erythrocytes. J Exp Med 1986;164:50-59.
40. 40. Minota S, et al. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody. Arthritis Rheum 1984;27:1329-1335.
41. 41. Rodriguez de Cordoba S, Rubinstein P. Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster. J Exp Med 1986;164:1274-1283.
42. 42. Dykman TR, Cole JL, Iida K, Atkinson JP. Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells. J Exp Med 1983;157:2160-2165.
43. 43. Ross GD, Newman SL, Lambris JD, Devery PJ, Cain JA, Lachmann PJ. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. J Exp Med 1983;158:334-352.
44. 44. Dobson NJ, Lambris JD, Ross GD. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies. J Immunol 1981;126:693-698.
45. 45. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson WA. Complement receptor type 1 (CR1, CD35) is a receptor for Clq. Immunity 1997;7:345-355.
46. 46. Arnaout MA, Melamed J, Tack BF, Colten HR. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. J Immunol 1981;127:1348-1354.
47. 47. Arnaout MA, Dana N, Melamed J, Medicus R, Colten HR. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology 1983;48:229-237.
48. 48. Pangburn MK. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases. J Immunol 1986;136:2216-2221.
49. 49. Paccaud JP, Carpentier JL, Schifferli JA. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane. J Immunol 1988;141:3889-3894.
50. 50. Chevalier J, Kazatchkine MD. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J Immunol 1989;142:2031-2036.
51. 51. Iida K, Nussenzweig V. Complement receptor is an inhibitor of the complement cascade. J Exp Med 1981;153:1138-1150.
52. 52. Farries TC, Seya T, Harrison RA, Atkinson JP. Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H. Complement Inflamm 1990;7:30-41.
53. 53. Krych-Goldberg M, et al. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem 1999;274:31160-31168.
54. 54. Ross GD, Lambris JD, Cain JA, Newman SL. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CRI cofactor activity. J Immunol 1982;129:2051-2060.
55. 55. Medof ME, Iida K, Mold C, Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 1982;156:1739-1754.
56. 56. Medof ME, Nussenzweig V. Control of the function of substrate-bound C4b-C3b by the complement receptor CR1. J Exp Med 1984;159:1669-1685.
57. 57. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med 1988;168:1699-1717.
58. 58. Krych M, Hourcade D, Atkinson JP. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci USA 1991;88:4353-4357.
59. 2 chimeric complement inhibitor. J Exp Med 1991;174:1451-1460.
60. 60. Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem 1994;269:13273-13278.
61. 61. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. Clq and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol 1999;163:5056-5063.
62. 62. Krych M, Hauhart R, Atkinson JP. Structure-function analysis of the active sites of complement receptor type 1. J. Biol Chem 1998;273:8623-8629.
63. 63. Birmingham DJ, Cosio FG. Characterization of the baboon erythrocyte C3b-binding protein. J Immunol 1989;142:3140-3144.
64. 64. Birmingham DJ, Cosio FG. C3b binding proteins of primate erythrocytes (E). Complement Inflamm 1989;6:315.
65. 65. Nickells MW, Subramanian VB, Clemenza L, Atkinson JP. Identification of complement receptor type-1 related proteins on primate erythrocytes. J Immunol 1995;154:2829-2837.
66. r complement receptor expressed on chimpanzee erythrocytes. J Immunol 1994;153:691-700.
67. 67. Hourcade D, Miesner DR, Bee C, Zeldes W, Atkinson JP. Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. An example of concerted (horizontal) evolution within a gene. J Biol Chem 1990;265:974-980.
68. 68. Birmingham DJ, Logar CM, Shen X-P, Chen W. The baboon erythrocyte complement receptor is a glycophosphatidylinositol-linked protein encoded by a homologue of the human CR1-like genetic element. J Immunol 1996;157:2586-2592.
69. 69. Chen W, Logar CM, Shen X-P, Birmingham DJ. The chimpanzee and cynomolgus monkey immune adherence receptors are encoded by CR1-like genes. Immunogenetics 2000;52:46-52.
70. 70. Birmingham DJ, Cosio FG. Determination of factor I cofactor function of nonhuman primate erythrocyte (E) C3b receptors. FASEB J 1990;4:2188.
71. 71. Edberg JC, Kimberly RP, Taylor RP. Functional characterization of non-human primate erythrocyte immune adherence receptors - implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system. Eur J Immunol 1992;22:1333-1339.
72. 72. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997;388:292-295.
73. 73. Rowe JA, et al. Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in resetting in field isolates. J Immunol 2000;165:6341-6346.
74. 74. Moulds J, et al. Molecular identification of Knops blood group polymorphisms found in LHR-D of complement receptor type 1 (CR1). Blood (In press).
75. 75. Cornacoff JB, Hebert LA, Smead WL, VanAmin ME, Birmingham DJ, Waxman FJ. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 1983;71:236-247.
76. 76. Cosio FG, et al. Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the non human primate. Clin Immunol Immunopathol 1987;42:1-9.
77. 77. Kimberly RP, Edberg JC, Merriam LT, Clarkson SB, Unkeless JC, Taylor RP. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest 1989;84:962-970.
78. 78. Birmingham DJ, Hebert LA, Cosio FG, VanAman ME. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med 1990;116:242-252.
79. 79. Waxman FJ, et al. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest 1984;74:1329-1340.
80. 80. Waxman FJ, et al. Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. J Clin Invest 1986;77:82-89.
81. 81. Lobatto S, et al. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol 1987;69:133-141.
82. 82. Schifferli JA, Ng YC, Estreicher J, Walport MJ. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complementand erythrocyte complement receptor 1-dependent mechanisms. J Immunol 1988;140:899-904.
83. 83. Schifferli JA, Ng YC, Paccaud JP, Walport MJ. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol 1989;75:329-335.
84. 84. Davies KA, et al. A study of in vivo immune complex formation and clearance in man. J Immunol 1990;144:4613-4620.
85. 85. Madi N, Steiger G, Estreicher J, Schifferli JA. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1991;85:373-378.
86. 86. Davies KA, Peters AM, Beynon HLC, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus - in vivo imaging and clearance studies. J Clin Invest 1992;90:2075-2083.
87. 87. Miyakawa Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M. Defective immune adherence receptor (C3b) on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981;II:493-497.
88. 88. Wilson JG, Wong WW, Schur PH, Fearon DT. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Eng J Med 1982;307:981-986.
89. 89. Wilson JG, Wong WW, Murphy EE, Schur PH, Fearon DT. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J Immunol 1987;138:2706-2710.
90. 90. Tausk F, Hoffmann T, Schreiber R, Gigli I. Leprosy: altered complement receptors in disseminated disease. J Invest Dermatol 1985;85:585-615.
91. 91. Tausk FA, McCutchan A, Spechko P, Schreiber RD, Gigli I. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 1986;78:977-982.
92. 92. Thomsen BS, et al. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1987;30:967-971.
93. 93. Somerville C, D'Apice A. Future directions in transplantation: xenotransplantation. Kidney Int 1993;44:S112-S121.
94. 94. Ross GD, et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol 1985;135:2005-2014.
95. 95. Uko G, Dawkins RL, Kay P, Christiansen FT, Hollingsworth PN. CR1 deficiency in SLE: acquired or genetic? Clin Exp Immunol 1985;62:329-336.
96. 96. Holme E, Fyfe A, Zoma A, Veitch J, Hunter J, Whaley K. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1986;63:41-48.
97. 97. Thomsen BS, Nielsen H, Andersen V. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE. Scand J Rheumatol 1987;16:339-346.
98. 98. Barbosa JE, Harrison RA, Barker PJ, Lachmann PJ. An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis. Clin Exp Immunol 1992;87:144-149.
99. 99. Ripoche J, Sim RB. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor. Biochem J 1986;235:815-821.
100. 100. Pascual M, Danielsson C, Steiger G, Schifferli JA. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur J Immunol 1994;24:702-708.
101. 101. Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397-404.
102. 102. Hebert LA, et al. Experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int 1991;39:44-56.
103. 103. Cosio FG, Shen XP, Birmingham DJ, Van AM, Hebert LA. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol 1990;145:4198-4206.
104. 104. Beynon HLC, Davies KA, Haskard DO, Walport MJ. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium. J Immunol 1994;153:3160-3167.
105. 105. Nielsen CH, Matthiesen SH, Lyng I, Leslie R. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes. Immunology 1997;90:129-137.
106. 106. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998;87:176-183.
107. 107. Xiang L, Rundles JR, Hamilton DR, Wilson JG. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 1999;163:4939-4945.
108. 108. Hebert LA, Birmingham DJ, Shen XP, Cosio FG. Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes. Clin Immunol Immunopathol 1992;62:301-306.
109. 109. Hebert LA, et al. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. Kidney Int 1994;45:493-199.
110. 110. Hebert LA, Birmingham DJ, Dillon JJ, Cosio FG, Shen XP. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol 1994;4:786-1791.
111. 111. Labuguen RH, Taylor RP, Zimmermann RL. E-rosette formation using heteropolymeric monoclonal antibodies. Immunol Lett 1992;32:175-180.
112. 112. Reist CJ, Liang HY, Denny D, Martin EN, Scheld WM, Taylor RP. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur J Immunol 1994;24:2018-2025.
113. 113. Powers JH, et al. Complement-independent binding of microorganisms to primate erythrocytes to vitro by cross-linked monoclonal antibodies via complement receptor 1. Infect Immun 1995;63:1329-1335.
114. 114. Ferguson PJ, et al. Antigen-based heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys. J Immunol 1995;155:339-347.
115. 115. Taylor RP, et al. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model. J Immunol 1997;159:4035-4044.
116. 116. Taylor RP, et al. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model. Clin Immunol Immunopathol 1997;82:49-59.
117. 117. Kuhn SE, Nardin A, Klebba PE, Taylor RP. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J Immunol 1998;160:5088-5097.
118. 118. Craig ML, Bankovich AJ, McElhenny JL, Taylor RP. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Arthritis Rheum 2000;43:2265-2275.
119. 119. Oudin S, et al. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/ CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes. J Immunol 2000;164:1505-1513.